
We have reviewed our experience with the treatment of 250 patients with deep vein zzso diagnosed by contrast zzso The level of zzso was recorded according to the zzso level to which it zzso A third of the patients had cancer, and the most common clinical findings were swelling and zzso The risk of the development of pulmonary zzso based on the zzso level of initial deep vein zzso revealed the zzso 12 of 115 patients (10 percent) with level I zzso deep vein zzso developed pulmonary zzso as did 2 of 27 patients (7 percent) with level II zzso disease, 5 of 60 (8 percent) with level III zzso disease, 1 of 19 patients (5 percent) with level IV zzso disease, and 2 of 26 patients (8 percent) with level V zzso zzso Based on our favorable experience with zzso we believe that zzso is the treatment of choice for deep vein zzso regardless of the zzso zzso The zzso of pulmonary embolism does not appear to be influenced significantly by the level of the deep vein zzso 

